College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea; Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
Int J Pharm. 2016 Dec 30;515(1-2):233-244. doi: 10.1016/j.ijpharm.2016.10.021. Epub 2016 Oct 12.
The objectives of the present study were to develop a controlled-release bilayered tablet of aceclofenac (AFN) 200mg with dual release and to gain a mechanistic understanding of the enhanced sustained release capability achieved by utilizing a binary mixture of the sustained release materials. Different formulations of the sustained-release layer were formulated by employing hydroxypropyl methylcellulose (HPMC) and hydroxypropyl cellulose (HPC) as the major retarding polymers. The in vitro dissolution studies of AFN bilayered tablets were carried out in intestinal fluid (pH 6.8 buffer). The mechanism of the synergistic rate-retarding effect of the polymer mixture containing HPC and carbomer was elucidated by the rate of swelling and erosion in intestinal fluid and the molecular interactions in the polymer network. The optimized bilayered tablets had similar in vitro dissolution profiles to the marketed tablet ClanzaCR based on the similarity factor (f2) in combination with their satisfactory micromeritic, physicochemical properties, and stability profiles. Drug release from HPMC-based matrix was controlled by non-Fickian transport, while drug release from HPC-based matrix was solely governed by drug diffusion. The swelling and erosion data exhibited a dramatic increase of water uptake and a reduction of weight loss in the polymer mixture-loaded tablet. Fourier transform infrared (FTIR) spectra revealed strong hydrogen bonding between HPC and carbomer in the polymer mixture. Regarding spatial distribution of polymers in the polymer mixture-loaded tablet, carbomer was found to be the main component of the gel layer during the first 2h of the hydration process, which was responsible for retarding drug release at initial stage. This process was then followed by a gradual transition of HPC from the glassy core to the gel layer for further increasing gel strength.
本研究的目的是开发一种含有 200mg 醋氯芬酸(AFN)的双层控释片剂,具有双重释放特性,并深入了解利用缓释材料的二元混合物来实现增强的持续释放能力的机制。通过使用羟丙基甲基纤维素(HPMC)和羟丙基纤维素(HPC)作为主要的缓释聚合物,来制备不同的缓释层配方。在肠液(pH6.8 缓冲液)中进行 AFN 双层片剂的体外溶出研究。通过在肠液中的溶胀和侵蚀速率以及聚合物网络中的分子相互作用,阐明了含有 HPC 和卡波姆的聚合物混合物的协同速率阻滞效应的机制。优化的双层片剂具有与市售 ClanzaCR 片剂相似的体外溶出曲线,这是基于相似因子(f2),再结合它们令人满意的微粉学、物理化学性质和稳定性曲线。基于 HPMC 的基质中的药物释放由非 Fickian 传输控制,而基于 HPC 的基质中的药物释放仅由药物扩散控制。溶胀和侵蚀数据显示,聚合物混合物负载片剂的吸水率显著增加,重量损失减少。傅里叶变换红外(FTIR)光谱显示 HPC 和卡波姆在聚合物混合物之间存在强烈的氢键。关于聚合物混合物负载片剂中聚合物的空间分布,发现卡波姆在水合过程的前 2 小时内是凝胶层的主要成分,负责在初始阶段延缓药物释放。然后,HPC 从玻璃态核心逐渐向凝胶层过渡,以进一步增加凝胶强度。